Cite

HARVARD Citation

    Ghazanfar, M. et al. (2016). Effectiveness and safety of omalizumab in chronic spontaneous or inducible urticaria: evaluation of 154 patients. British journal of dermatology. pp. 404-406. [Online]. 
  
Back to record